Patient info Open main menu

OLMESARTAN MEDOXOMIL/HYDROCHLOROTHIAZIDE 40 MG / 25 MG FILM-COATED TABLETS - patient leaflet, side effects, dosage

Dostupné balení:

Patient leaflet - OLMESARTAN MEDOXOMIL/HYDROCHLOROTHIAZIDE 40 MG / 25 MG FILM-COATED TABLETS

accord

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT

Olmesartan Medoxomil/ Hydrochlorothiazide 40 mg/12.5 mg film-coated tablets

Olmesartan Medoxomil/

I

Hydrochlorothi­azide 40 mg/25 mg film-coated tablets

Olmesartan Medoxomil/Hydrochlo­rothiazide

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

What is in this leaflet

  • 1. What Olmesartan Medoxomil/Hydrochlo­rothiazide tablets are and what they are used for

  • 2. What you need to know before you take Olmesartan Medoxomil/Hydrochlo­rothiazide tablets

  • 3. How to take Olmesartan Medoxomil/Hydrochlo­rothiazide tablets

  • 4. Possible side effects

  • 5. How to store Olmesartan Medoxomil/Hydrochlo­rothiazide tablets

  • 6. Contents of the pack and other information

  • 1. What Olmesartan Medoxomil/ Hydrochlorothiazide tablets are and what they are used for

i

Olmesartan Medoxomil/Hydrochlo­rothiazide tablets contains two active substances, olmesartan medoxomil and hydrochlorothi­azide, that are used to treat high blood pressure (hypertension):

i

  • Olmesartan medoxomil is one of a group of medicines called angiotensin II-receptor antagonists. It lowers blood pressure by relaxing the blood vessels.
  • Hydrochlorothiazide is one of a group of medicines called thiazide diuretics (“water tablets”). It lowers blood pressure by helping the body to get rid of extra fluid by making your kidneys produce more urine.

You will only be given Olmesartan Medoxomil/ Hydrochlorothiazide tablets if olmesartan medoxomil alone has not adequately controlled your blood pressure. When given together, the two active substances in Olmesartan Medoxomil/Hydrochlo­rothiazide tablets help to lower blood pressure more than if either of them were given alone.

You may already be taking medicines to treat your high blood pressure, but your doctor may want you to take Olmesartan Medoxomil/Hydrochlo­rothiazide tablets to lower it more.

High blood pressure can be controlled with medicines such as Olmesartan Medoxomil/Hydrochlo­rothiazide tablets.Your doctor has probably also recommended that you make some changes in your lifestyle to help lower your blood pressure (for example losing weight, giving up smoking, reducing the amount of alcohol you drink and reducing the amount of salt in your diet). Your doctor may also have urged you to take regular exercise, such as walking or swimming. It is important to follow this advice from your doctor.

i

2. what you need to know before you take olmesartan medoxomil/ hydrochlorothiazide tablets

Do not take Olmesartan Medoxomil/Hydrochlo­rothiazide tablets

  • if you are allergic to olmesartan medoxomil or hydrochlorothi­azide, or any of the other ingredients of this medicine (listed in section 6) or substances similar to hydrochlorothiazide (sulfonamides)
  • if you are more than 3 months pregnant (It is also better to avoid Olmesartan Medoxomil/Hydrochlo­rothiazide tablets in early pregnancy – see pregnancy section)
  • if you have severe kidney problems
  • if you have diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren
  • if you suffer from low potassium, low sodium, high calcium or high uric acid levels in the blood (with symptoms of gout or kidney stones) that do not get better when treated
  • if you suffer from moderate or severe liver problems or yellowing of the skin and eyes (jaundice) or problems with drainage of the bile from the gallbladder (biliary obstruction e.g. gallstones)

If you think any of these apply to you, or you are unsure, do not take the tablets. Talk to your doctor first and follow the advice given.

I

Warnings and precautions

Talk to your doctor or pharmacist or nurse before taking Olmesartan Medoxomil/Hydrochlo­rothiazide tablets.

I

Before you take the tablets, tell your doctor if you are taking any of the following medicines used to treat high blood pressure:

  • an ACE-inhibitor (for example enalapril, lisinopril, ramipril), in particular if you have diabetes-related kidney problems.
  • aliskiren

I

Your doctor may check your kidney function, blood pressure, and the amount of electrolytes (e.g. potassium) in your blood at regular intervals.

I

See also information under the heading “Do not take Olmesartan Medoxomil/Hydrochlo­rothiazide tablets ”.

Before you take the tablets, tell your doctor if you have any of the following health problems:

  • Kidney transplant
  • Liver diseases
  • Heart failure or problems with your heart valves or heart muscles
  • Vomiting (being sick) or diarrhoea which is severe or it goes on for several days
  • Treatment with high doses of water tablets (diuretics) or if you are on a low salt diet
  • Problems with your adrenal glands (e.g. primary aldosteronism)
  • Diabetes
  • Lupus erythematosus (an autoimmune disease)
  • Allergies or asthma.
  • if you have had skin cancer or if you develop an unexpected skin lesion during the treatment. Treatment with hydrochlorothi­azide, particularly long term use with high doses, may increase the risk of some types of skin and lip cancer (non-melanoma skin cancer). Protect your skin from sun exposure and UV rays while taking Olmesartan Medoxomil/Hydrochlo­rothiazide tablets.

I

Contact your doctor if you experience any of the following symptoms:

  • diarrhoea that is severe, persistent and causes substantial weight loss. Your doctor may evaluate your symptoms and decide on how to continue your blood pressure medication.
  • decrease in vision or eye pain. These could be symptoms of fluid accumulation in the vascular layer of the eye (choroidal effusion) or an increase of pressure in your eye and can happen within hours to weeks of taking Olmesartan Medoxomil/Hydrochlo­rothiazide tablets. This can lead to permanent vision impairment, if not treated.

I

Your doctor may want to see you more often and do some tests if you have any of these conditions.

Olmesartan Medoxomil/Hydrochlo­rothiazide tablets may cause a rise in blood fat levels and uric acid levels (the cause of gout – painful swelling of the joints). Your doctor will probably want to do a blood test from time to time to check these.

It may change the levels of certain chemicals in your blood called electrolytes. Your doctor will probably want to do a blood test from time to time to check these. Signs of electrolyte changes are: thirst, dryness of the mouth, muscle pain or cramps, tired muscles, low blood pressure (hypotension), feeling weak, sluggish, tired, sleepy or restless, nausea, vomiting, less need to pass urine, a rapid heart rate. Tell your doctor if you notice these symptoms.

As with any medicine which reduces blood pressure, an excessive drop in blood pressure in patients with blood flow disturbances of the heart or brain could lead to a heart attack or stroke. Your doctor will therefore check your blood pressure carefully.

If you are due to have tests for parathyroid function, you should stop taking Olmesartan Medoxomil/Hydrochlo­rothiazide tablets before these tests are carried out.

You must tell your doctor if you think that you are (or might become) pregnant. Olmesartan Medoxomil/Hydrochlo­rothiazide tablets are not recommended in early pregnancy, and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used at that stage (see pregnancy section).

Children and adolescents

Olmesartan Medoxomil/Hydrochlo­rothiazide tablets are not recommended for children and adolescents under the age of 18.

Other medicines and Olmesartan Medoxomil/Hydrochlo­rothiazide tablets

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines

In particular, tell your doctor or pharmacist about any of the following:

  • Other blood pressure lowering medicines (anti-hypertensives), as the effect of Olmesartan Medoxomil/Hydrochlo­rothiazide tablets can be increased. Your doctor may need to change your dose and/or to take other precautions:

If you are taking an ACE-inhibitor or aliskiren (see also information under the headings “Do not take Olmesartan Medoxomil/Hydrochlo­rothiazide tablets ” and “Warnings and precautions”).

  • Medicines which may alter the levels of potassium in your blood if used at the same time as Olmesartan Medoxomil/Hydrochlo­rothiazide tablets. These include: – potassium supplements (as well as salt substitutes containing potassium)
  • – water tablets (diuretics)

  • – heparin (for thinning the blood)

  • – laxatives

  • – steroids

  • – adrenocortico­trophic hormone (ACTH)

  • – carbenoxolone (a medicine used to treat mouth and stomach ulcers)

  • – penicillin G sodium (also called benzylpenicillin sodium, an antibiotic)

  • – certain pain killers such as aspirin or salicylates

  • Lithium (a medicine used to treat mood swings and some types of depression) used at the same time as Olmesartan Medoxomil/Hydrochlo­rothiazide tablets may increase the toxicity of lithium. If you have to take lithium, your doctor will measure your lithium blood levels.
  • Non-steroidal anti-inflammatory (NSAIDs) medicines (medicines used to relieve pain, swelling and other symptoms of inflammation, including arthritis) used at the same time as Olmesartan Medoxomil/Hydrochlo­rothiazide tablets may increase the risk of kidney failure and the effect of Olmesartan Medoxomil/Hydrochlo­rothiazide tablets can be decreased by NSAIDs.
  • Sleeping tablets, sedatives and anti-depressant medicines, as using these medicines together with Olmesartan Medoxomil/Hydrochlo­rothiazide tablets may cause a sudden drop in blood pressure when standing up.
  • Certain medicines such as baclofen and tubocurarine, used to relax muscles.
  • Amifostine and some other drugs used to treat cancers, such as cyclophosphamide or methotrexate.
  • Colestyramine and colestipol, medicines for lowering blood fat levels.
  • Colesevelam hydrochloride, a drug that lowers ' the level of cholesterol in your blood, as the effect I of Olmesartan Medoxomil/Hydrochlo­rothiazide | tablets may be decreased. Your doctor may । advise you to take Olmesartan Medoxomil/Hydrochlo­rothiazide tablets at least 4 hours before colesevelam hydrochloride.
  • Anticholinergic agents, such as atropine and biperiden.
  • Drugs such as thioridazine, chlorpromazine, levomepromazine, trifluoperazine, cyamemazine, sulpiride, amisulpride, pimozide, sultopride, tiapride, droperidol or haloperidol, used to treat certain psychiatric disorders.
  • Certain medicines such as quinidine, hydroquinidine, disopyramide, amiodarone, sotalol or digitalis, used to treat heart problems.
  • Medicines such as mizolastine, pentamidine, terfenadine, dofetilide, ibutilide or erythromycin injections, which may change the heart rhythm.
  • Oral anti-diabetic medicines, such as metformin, or insulin, used to lower blood sugar.
  • Beta-blockers and diazoxide, medicines used to treat high blood pressure or low blood sugar, respectively, as Olmesartan Medoxomil/Hydrochlo­rothiazide tablets can enhance their blood-sugar-increasing effect.
  • Methyldopa, a medicine used to treat high blood pressure.
  • Medicines such as noradrenaline, used to increase blood pressure and slow heart rate.
  • Diphemanil, used to treat a slow heartbeat or reduce sweating.
  • Medicines such as probenecid, sulfinpyrazone and allopurinol, used to treat gout.
  • Calcium supplements.
  • Amantadine, an anti-viral drug.
  • Ciclosporin, a medicine used to stop rejection of organ transplants.
  • Certain antibiotics called tetracyclines or sparfloxacin.
  • Amphotericin, a medicine used to treat fungal infections.
  • Certain antacids, used to treat too much stomach acid, such as aluminium magnesium hydroxide, as the effect of Olmesartan Medoxomil/Hydrochlo­rothiazide tablets can be slightly decreased.
  • Cisapride, used to increase food movement in the stomach and gut.
  • Halofantrine, used for malaria.

Olmesartan Medoxomil/Hydrochlo­rothiazide tablets with food and drink

Olmesartan Medoxomil/Hydrochlo­rothiazide tablets can be taken with or without food.

Take care when drinking alcohol while you are taking Olmesartan Medoxomil/Hydrochlo­rothiazide tablets , as some people feel faint or dizzy. If this happens to you, do not drink any alcohol, including wine, beer or alcopops.

Black patients

As with other similar drugs the blood pressure lowering effect of Olmesartan Medoxomil/Hydrochlo­rothiazide tablets are somewhat less in black patients.

Pregnancy breast-feeding

Pregnancy

You must tell your doctor if you think you are (or might become) pregnant. Your doctor will normally advise you to stop taking Olmesartan Medoxomil/Hydrochlo­rothiazide tablets before you become pregnant or as soon as you know you are pregnant and will advise you to take another medicine instead of Olmesartan Medoxomil/Hydrochlo­rothiazide tablets. Olmesartan Medoxomil/Hydrochlo­rothiazide tablets are not recommended during pregnancy, and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if it is used after the third month of pregnancy.

Breast-feeding

Tell your doctor if you are breast-feeding or about to start breast-feeding.

Olmesartan Medoxomil/Hydrochlo­rothiazide tablets are not recommended for mothers who are breast-feeding, and your doctor may choose another treatment for you if you wish to breast-feed.

If you are pregnant or breast-feeding, think you may be Some changes in blood results have also been

pregnant or are planning to have a baby, ask your doctor or seen and include:

pharmacist for advice before taking this medicine. Increase in blood creatinine, urea, calcium and

sugar levels, decrease in blood chloride, potassium, magnesium and sodium levels. Increase of serum amylase (hyperamylasaemia).


Driving and using machines

I

You may feel sleepy or dizzy while being treated for your high blood pressure. If this happens, do not drive or use machines until the symptoms wear off. Ask your doctor for advice.

Olmesartan Medoxomil/Hydrochlo­rothiazide tablets contains lactose monohydrate

I

This medicine contains lactose (a type of sugar). If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.

3. how to take olmesartan medoxomil/ hydrochlorothiazide tablets

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

The recommended dose is one Olmesartan Medoxomil/Hydrochlo­rothiazide tablets 40 mg/12.5 mg tablet a day. However, if your blood pressure is not controlled, your doctor may decide to change your dose to one Olmesartan Medoxomil/Hydrochlo­rothiazide tablets 40 mg/25 mg tablet a day.

Swallow the tablet with water. If possible, you should take your dose at the same time each day , for example at breakfast time. It is important to continue to take Olmesartan Medoxomil/Hydrochlo­rothiazide tablets until your doctor tells you to stop.

If you take more Olmesartan Medoxomil/ Hydrochlorothiazide tablets than you should i

If you take more tablets than you should, or if a child accidentally swallows one or more, go to your doctor or nearest accident and emergency (A&E) department immediately and take your medicine pack with you.

If you forget to take Olmesartan Medoxomil/ Hydrochlorothiazide tablets

i

If you forget to take a dose, take your normal dose on the following day as usual. Do not take a double dose to make up for a forgotten dose.

i

If you stop taking Olmesartan Medoxomil/ Hydrochlorothiazide tablets

It is important to continue to take Olmesartan Medoxomil/ Hydrochlorothiazide tablets unless your doctor tells you to stop. i

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

i

However, the following two side effects can be serious:

i

  • Allergic reactions that may affect the whole body, with swelling of the face, mouth and/or voice box (larynx) together with itching and rash may occur rarely. If this happens, stop taking Olmesartan Medoxomil/Hydrochlo­rothiazide tablets and contact your doctor immediately.

i

  • Olmesartan Medoxomil/Hydrochlo­rothiazide tablets can cause the blood pressure to fall too low in susceptible individuals or as the result of an allergic reaction.

5. how to store olmesartan medoxomil/ hydrochlorothiazide tablets

Keep this medicine out of the sight and reach of children.

This medicinal product does not require any special storage conditions.

Do not use this medicine after the expiry date which is stated on the carton and on the blister strip as EXP. The expiry date refers to the last day of that month.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. contents of the pack and other information

What Olmesartan Medoxomil/Hydrochlo­rothiazide tablets contains

The active substances of Olmesartan Medoxomil/Hydrochlo­rothiazide tablets are:

Olmesartan Medoxomil/Hydrochlo­rothiazide tablets 40 mg/12.5 mg: Each film-coated tablet contains 40 mg olmesartan medoxomil and 12.5 mg hydrochlorothi­azide. Olmesartan Medoxomil/Hydrochlo­rothiazide tablets 40 mg/25 mg: Each film-coated tablet contains 40 mg olmesartan medoxomil and 25 mg hydrochlorothi­azide.

The other ingredients are:

Hydroxy propyl cellulose, Lactose monohydrate, Cellulose microcrystalline, Low substituted Hydroxy propyl cellulose, Magnesium stearate, Hypromellose, Titanium dioxide (E171), Macrogol 3000, Talc, Iron oxide yellow (E172), Iron oxide red (E172)

What Olmesartan Medoxomil/Hydrochlorothiazide tablets looks like and contents of the pack

Olmesartan Medoxomil/Hydrochlo­rothiazide tablets 40/12.5 mg are Reddish-Yellow, oval film-coated tablets; debossed with “OH2” on one side and plain on other side. Approximate dimensions: Length 15.3 mm, width 7.1 mm.

Olmesartan Medoxomil/Hydrochlo­rothiazide tablets 40/25 mg are Pinkish, oval film-coated tablets; debossed with “OH3” on one side and plain on other side.

Approximate dimensions: Length 15.3 mm, width 7.1 mm.

Olmesartan Medoxomil/Hydrochlo­rothiazide tablets 40/12.5 mg and 40/25 mg are available in Alu-Alu blister containing 10, 14, 28, 30, 56, 84, 90, 98, 280 or 300 tablets or in Alu-Alu perforated unit dose blisters containing 10, 28, 50 or 500 tablets.

Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder

United Kingdom

Accord Healthcare Limited

Sage House, 319 Pinner Road, North Harrow, Middlesex,

HA1 4HF, United Kingdom

Ireland

Accord Healthcare Ireland Limited

Euro House

Euro Business Park

Little Island

Cork T45 K857

Ireland

Manufacturer

Accord Healthcare Limited,

Sage House, 319 Pinner Road, North Harrow, Middlesex,

HA1 4HF, United Kingdom

Accord Healthcare Polska Sp.z o.o.,

ul. Lutomierska 50,95–200 Pabianice, Poland

The medicinal product is authorized in the Member States of the EEA under the following names:

Name of :

Name of medicinal product

member state

AT :

Olmesartan Medoxomil/

FI :

Hydrochlorothiazide Accord 40/12.5 mg, 40/25 mg Filmtabletten

Olmesartan Medoxomil/

IE :

Hydrochlorothiazide Accord

Olmesartan Medoxomil/

IT :

Hydrochlorothiazide Accord 40/12.5 mg, 40/25 mg film-coated tablets Olmesartan medoxomil e idroclorotiazide

NL :

Accord

Olmesartan Medoxomil/

UK :

Hydrochloorthiazide Accord 40/12,5 mg, 40/25 mg filmomhulde tabletten

Olmesartan Medoxomil/

ES :

Hydrochlorothiazide 40/12.5 mg, 40/25 mg film-coated tablets

Olmesartan medoxomilo/Hi­droclorotiazi­da ।

Accord 40/12.5 mg, 40/25 mg comprimidos recubiertos con pehcula

This leaflet was last approved in 06/2020.

INP097

10 2453 1 691022

Back Side